StempeucelOA™, mesenchymal stem cells for treatment of osteoarthritis
Stempeucel is comprised of autologous, ex vivo-expanded bone marrow-derived mesenchymal stem cells. This study aims to assess the safety and tolerability of a single dose of intraarticularly injected Stempeucel in patients with osteoarthritis of the knee.
Read More
Product Information for
StempeucelOA™, mesenchymal stem cells for treatment of osteoarthritis